Key facts
- This page summarizes EcoR1 Capital, LLC's Form 3 filing for Mirati Therapeutics, Inc..
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 27 Dec 2023, 16:04.
EcoR1 Capital, LLC - 18 Dec 2023 Form 3 Insider Report for Mirati Therapeutics, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 18 Dec 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 27 Dec 2023, 16:04:25 UTC
- Prior SEC filing
- 16 Oct 2023
- Next SEC filing
- 28 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Oleg Nodelman, Manager of EcoR1 Capital, LLC
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
EcoR1 Capital, LLC filed Form 3 for Mirati Therapeutics, Inc. on 27 Dec 2023.
Change
- Previous filing in this sequence was filed on 16 Oct 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MRTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,396,979
- Date
- 18 Dec 2023
- Ownership
- See Note
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1") and Oleg Nodelman. EcoR1 is the general partner and investment adviser of private funds (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself and Mr. Nodelman. The Filers are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests therein.